About Gland Pharma Ltd
Gland Pharma is primarily engaged in manufacturing injectable formulations.
Founded
1978
CEO
SRINIVAS SADU
Employees
4,332
HQ
Hyderabad, Telangana
Finished Products
1Sale of Products
₹18,612.93Cr2Service Income
₹1,946.91Cr3Export incentives
₹104.91Cr4Other Operating Revenue
₹34.50CrRaw Materials
1Raw Material Consumed
₹7,137.68Cr2Purchase
₹69.90CrAbout Gland Pharma Ltd
Gland Pharma is primarily engaged in manufacturing injectable formulations.
Founded:1978
CEO:SRINIVAS SADU
Employees:4,332
HQ:Hyderabad, Telangana
Finished Products
1Sale of Products
₹18,612.93Cr2Service Income
₹1,946.91Cr3Export incentives
₹104.91Cr4Other Operating Revenue
₹34.50CrRaw Materials
1Raw Material Consumed
₹7,137.68Cr2Purchase
₹69.90CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹3,040
52W Low
₹1,574
Volume556.48K
Avg VolumeN/A
Beta0.63
Dividend Yield0.70%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
41.87x
Valuation
P/B Ratio
4.56x
Valuation
EPS
₹68.43
Valuation
Dividend Yield
0.70%
Valuation
ROE
9.92%
Profitability
ROCE
14.02%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
8.6%
International
91.4%
USA48.5%
Europe21.9%
Rest Of The World17.4%
India8.6%
Canada2.2%
Australia1.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.03x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.